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Abstract:  
In this paper a new method based on artificial neural networks (ANN), is introduced for identifying pathogenic antibodies in Systemic Lupus 
Erythmatosus (SLE).  dsDNA binding antibodies have been implicated in the pathogenesis of this autoimmune disease.  In order to identify these dsDNA 
binding antibodies, the protein sequences of 42 dsDNA binding and 608 non-dsDNA binding antibodies were extracted from Kabat database and encoded 
using a physicochemical property of their amino acids namely Hydrophilicity.  Encoded antibodies were used as the training patterns of a general 
regression neural network (GRNN). Simulation results show that the accuracy of proposed method in recognizing dsDNA binding antibodies is 83.2%.  
We have also investigated the roles of the light and heavy chains of anti-dsDNA antibodies in binding to DNA.  Simulation results concur with the 
published experimental findings that in binding to DNA, the heavy chain of anti-dsDNA is more important than their light chain. 
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Background: 
Systemic Lupus Erythematosus (SLE or 'lupus') is a major autoimmune 
rheumatic disease where autoantibodies frequently target against 
intracellular
 antigens of the cell nucleus (double and single stranded DNA). 
According to the result of an experiment on more than five million U.S. 
Armed Forces personnel, in 115 of the 130 patients with SLE (88 percent), 
at least one SLE autoantibody tested was present 3.3 years before the 
diagnosis [1]. This fact suggests that SLE can be predicted several years 
before the diagnosis. 
 
In patients with SLE, a wide variety of antibodies against nuclear antigens 
can be found, including antibodies to nucleic acids, histones and non-
histone nuclear proteins. However, anti-dsDNA antibodies are considered 
the most important autoantiboies in SLE. These antibodies were identified, 
for the first time, nearly forty years ago in the serum of patients with SLE 
[2]. Based on similar findings, many researchers have concluded that there 
is a close relationship between disease activity and levels of anti-dsDNA 
antibodies. In other words, dsDNA binding antibodies have been 
implicated in the pathogenesis of this autoimmune disease [3].  
 
Anti-dsDNA antibodies seem highly likely to cause tissue damage in 
patients with SLE. They are present in the serum of patients several years 
before its diagnosis. Therefore, their identification and analysis may be 
useful in the identification of patients who would benefit from early 
diagnosis, as well as patients who do not require further evaluation. In 
addition, a powerful method of their analysis may lead to design of new 
drugs that interfere with antibody–DNA interactions, which might have 
therapeutic applications. 
 
Recently, bioinformatics approaches, including statistical techniques and 
intelligent systems, have tried to obtain a better grasp of the DNA-binding 
structures and utilize them in an early prediction of autoimmune diseases 
such as SLE.  Although these kinds of works have been able to explain 
many biological phenomena, lead to the development of mathematical 
models for prediction and lead to reduction in the cost of experimental 
research, there is still no accurate mathematical method for identifying 
dsDNA binding antibodies [4].  We can trace the roots of this difficulty in 
the long amino acid sequence of antibodies, lack of suitable mathematical 
tools, and more importantly the vast diversity of antibodies. 
 
In this paper, we extended the computer-assisted autoantibody analysis 
methods by proposing a new approach with the capability of identifying 
dsDNA binding antibodies.  The proposed identification system is 
constructed using a General Regression Neural Network (GRNN).     
 
In the proposed method, we encode the amino acid sequence of antibodies 
using Hydrophilicity values of amino acids.  These signals are fed to a 
GRNN.  In order to better interpret the role of different parts of the anti-
dsDNA antibodies, we have investigated the roles of light and heavy 
chains and their bindings to DNA.  In general, the proposed method 
provides an efficient and accurate method to identify the dsDNA.   
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Figure 1: (a) Architecture of the of dsDNA binding antibodies identification system in training phase. (b) Architecture of dsDNA binding antibodies 
identification system in testing phase 
 
Methodology: 
Dataset 
In order to use ANN to identify dsDNA binding antibodies the training set 
needs to include a set of anti-dsDNA, as the positive set, and a set of other 
non dsDNA binding antibodies, as the negative set.  Our training data set 
was constructed using the Kabat database.  Kabat antibody sequence 
database contains primary structure and sequence information on 
antibodies and other proteins of immunological interest [5].  There are 42 
sequences of anti-dsDNA (both heavy and light chains) available in the 
Kabat database, which we used as positive patterns, and we took 608 of the 
other non dsDNA binding antibody sequences (both heavy and light 
chains) as negative patterns. 
 
Encoding: 
As we know, Immunoglobulins are heavy plasma proteins, composed of 20 
different amino acids. From a one-dimensional point of view, a protein 
sequence contains characters of these 20 amino acids. In other words, 
function of a protein depends on its specific amino acid sequence called 
the primary sequence structure [6]-[8]. 
 
An important issue in applying computer-based systems to identify dsDNA 
binding antibodies is how to encode protein sequences; i.e., how to 
represent the protein sequences as the input of a system.  This is crucial to 
the success of neural network learning process.  Several different methods 
have been used for encoding proteins.  For example, Wu [9] has utilized 
the 2-gram encoding method, which extracts various patterns of two 
consecutive amino acid residues in a protein sequence and counts the 
number of occurrences of the extracted residue pairs. Huang [10] has 
employed another encoding technique using six physiochemical properties 
(attributes) of amino acids, namely, composition, predicted secondary 
structure, hydrophobicity, normalized Van Der Waals volume, polarity, 
and polarizability.   
 
In fact, amino acids have many physiochemical properties such as 
isoelectric pH, surface area, hydrophilicity, polarity and the ability of 
reaction between the ion and the electron [11]-[14]. In this work, we have 
used just one physiochemical property of amino acids, which called 
Hydrophilicity, for encoding the protein sequence. In other words, the 
normalized number of the Hydrophilicity of the amino acid is used instead 
of each amino acid in the protein sequence.  Consequently, each antibody 
was transformed into an array, which is used as the input of the GRNN. 
 
Evaluation Criterion: 
As mentioned, new method based on ANNs, is introduced for identifying 
pathogenic antibodies in SLE. The efficacy of the proposed method is 
evaluated by calculating the following three parameters: positive accuracy, 
negative accuracy, and general accuracy. (See supplementary material) 
 
Anti-dsDNA Identifier: 
As mentioned, for the simulation a GRNN was used. For training and 
testing of the proposed system, we have formed a database, from the 
KABAT database, consisting of 42 anti-dsDNAs, as the positive data set, 
and 608 other antibodies, as the negative data set. 
 
A. Training Phase: 
To train the GRNN, a training set is formed by randomly choosing 33 
positive and 99 negative samples from our database. Figure. 1(a) 
illustrates the general architecture of the system in training phase. In the 
first layer, each antibody is encoded into an array, based on normalized 
quantities of the amino acids, Hydrophilicity. In the second layer, a GRNN 
is trained by arrays obtained from the previous layer so that +1 is assigned 
as the output for positive samples and -1 is assigned as the output for 
negative samples. 
 
B. Testing Phase: 
To test the proposed scheme, a testing set is formed by randomly choosing 
9 positive and 27 negative samples from the part of our database that was 
not used in the training set.  
 
Architecture of dsDNA binding antibodies identification system in testing 
phase is illustrated in Fig. 1.b. In the first layer, like the training phase, 
each antibody is encoded into a discrete signal, based on normalized 
quantities of the amino acids Hydrophilicity property. In the second layer, 
signals from the previous step are fed to the neural network.  The output of 
each network will be a number between -1 and +1.  By considering a 
threshold number between -1 and +1, we can separate the anti-dsDNAs 
from other antibodies.  This threshold was selected to be -0.9. 
 
Discussion: 
It is important to note that no mathematical method has been introduced 
for identifying anti-dsDNA antibodies yet. Therefore, we could not 
compare the effectiveness of proposed method with any other introduced 
scheme.  
 
In order to assure the validity of the results, the training, and testing phases 
of the proposed system were repeated 100 times and the final results were 
calculated by averaging over all 100 runs.  
 
Positive Accuracy,  Negative Accuracy and  General Accuracy obtained 
using the proposed methods are 78.55, 82.92 and 81.83, respectively. For    
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investigating the roles of light and heavy chains of anti-dsDNA antibodies 
in binding to DNA, an experiment was also designed. Heavy chain and 
light chain of antibodies were extracted from the Kabat database.  Next, we 
repeated the last simulation using heavy and light chains.  Table 1 contains 
these results (see supplementary material).  
 
As illustrated in Table 1 (see supplementary material), the heavy chain 
of anti-dsDNA is more important than the light chain in binding to DNA. 
Our simulation results confirm the experimental studies [16, 17].  Results 
indicated in Table II show that the proposed method, using heavy and light 
chains, provides a more accurate identification of anti-dsDNA than the 
heavy chain or light chain alone.  The reason is that by considering a more 
inclusive model, we are including more information and therefore, we 
should expect better results. Results of Table I also indicate higher 
numbers for negative accuracies.  This is because we have more negative 
(non anti-dsDNA) samples. Deleted 
 
We should mention that in this work negative accuracy (non-dsDNA 
binding antibodies) is more important than positive accuracy.   
Furthermore, the available data corresponding to the protein sequence for 
non-dsDNA binding antibodies are much more available than their 
counterparts.  Using unequal number of data points for non-dsDNA and 
dsDNA during training will introduce some bias, but as it was mentioned 
since the negative accuracy is more important this action is justified.   
Simulations using equal number of data points for non-dsDNA and dsDNA 
produced much lower negative and general accuracy. 
 
Conclusion: 
In this paper, we have introduced a new method for identifying pathogenic 
antibodies in SLE based on GRNN.  For identification of dsDNA binding 
antibodies, the protein sequence of 42 dsDNA binding and 608 non-
dsDNA binding antibodies were extracted from the KABAT database.   
Next, they were encoded using Hydrophilicity values of their amino acids.  
Coded antibodies were used to train a GRNN.  The simulation results 
indicate that the proposed method is very accurate in recognizing anti-
dsDNA antibodies. We have also investigated the roles of light and heavy 
chains of anti-dsDNA antibodies in binding to DNA.  Our simulation 
results confirmed the experimental findings that the heavy chain is more 
important than the light chain in regard to binding to DNA. 
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Supplementry material: 
 
Table 1: Associated accuracies using heavy chain, light chain and the proposed method 
  Positive  
Accuracy 
Negative  
Accuracy 
General  
Accuracy 
Heavy chain  80.77 76.48 77.55 
Light chain  78 69 71.3 
Proposed method 
(using both heavy  
and light chains) 
78.55 82.92 81.83 
 
 